2015
DOI: 10.1016/j.pbb.2015.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Prototypical anxiolytics do not reduce anxiety-like behavior in the open field in C57BL/6J mice

Abstract: Understanding and effectively treating anxiety disorders are a challenge for both scientists and clinicians. Despite a variety of available therapies, the efficacy of current treatments is still not optimal and adverse side effects can result in non-compliance. Animal models have been useful for studying the underlying biology of anxiety and assessing the anxiolytic properties of potential therapeutics. The open field (OF) is a commonly used assay of anxiety-like behavior. The OF was developed and validated in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
34
0
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(35 citation statements)
references
References 77 publications
(101 reference statements)
0
34
0
1
Order By: Relevance
“…Thus, it is tempting to suggest that SERT antagonism by cocaine reduces the potentially anxiogenic effect of being injected with a powerful psychoactivating agent. However, the interpretation of centre/surround measure as an anxiety measure has also been questioned due to the failure of mouse strains (particularly the C57BL/6 background of our SERT Met172 line) to be sensitive to prototypical anxiolytic drugs (Thompson et al, ). As the latter agents typically act via GABAergic mechanisms, it is possible that the broader actions of these agents may confound attempts to use pharmacology to attribute predictive validity to this measure.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, it is tempting to suggest that SERT antagonism by cocaine reduces the potentially anxiogenic effect of being injected with a powerful psychoactivating agent. However, the interpretation of centre/surround measure as an anxiety measure has also been questioned due to the failure of mouse strains (particularly the C57BL/6 background of our SERT Met172 line) to be sensitive to prototypical anxiolytic drugs (Thompson et al, ). As the latter agents typically act via GABAergic mechanisms, it is possible that the broader actions of these agents may confound attempts to use pharmacology to attribute predictive validity to this measure.…”
Section: Discussionmentioning
confidence: 99%
“…Diazepam-induced increases in locomotion have been noted elsewhere, with other inbred strains of mice under other lighting conditions at doses below those that indicated behavioral sedation (Cole and Rodgers 1995; Rodgers et al 1992), including B6 mice (LaBuda and Fuchs 2001; Lepicard et al 2000). Additionally, several reports suggest that B6 mice may not be as sensitive to the anxiolytic effects of prototypical anxiolytic drugs, compared to other strains (Griebel et al 2000; Thompson et al 2015). …”
Section: Discussionmentioning
confidence: 99%
“…The above conflicting results were mostly obtained in unconditioned tests of anxiety, which have been reported to produce inconsistent results with a wide range of psychoactive compounds (Andrews et al, 2014;Cryan & Sweeney, 2011;Griebel & Holmes, 2013;Miczek & de Wit, 2008;Rodgers et al, 1995Rodgers et al, , 2002; Thompson et al, 2015). One of the major limitations of these tests is that they cannot be used for more Correspondence: Dr. A. Ennaceur, Sunderland Pharmacy School, University of Sunderland, Wharncliffe Street, Sunderland, SR1 3SD, UK.…”
Section: Introductionmentioning
confidence: 99%